ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

Professional Societies: ACCI Selects UPCI To Manage Operations; Elects New Officers

December 3, 1999

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

DCT Concepts Approved

October 11, 1985

In Brief: Beatrice Mintz Appointed to Pontifical Academy; Three Americans Asked to Help Shanghai Group

November 28, 1986